$257.19
2.340.92%
At close: -
$256.19
-1.00-0.39%
After Hours: 4:00 PM EDT
Comments
Loading...
Alnylam Pharmaceuticals Stock Guidance | NASDAQ:ALNY | Benzinga
Alnylam Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | ALNY | Alnylam Pharmaceuticals | FY | 2025 | — | — | — | $2.70B | $3.00B | $2.68B | Get Alert |
| 10/31/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $2.15B | $2.30B | $2.23B | Get Alert |
| 08/01/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $2.15B | $2.30B | $1.88B | Get Alert |
| 05/02/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.85B | Get Alert |
| 02/15/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.78B | Get Alert |
| 11/02/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.77B | $1.91B | $1.44B | Get Alert |
| 08/03/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.44B | Get Alert |
| 05/04/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.39B | Get Alert |
| 02/23/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.48B | Get Alert |
| 10/27/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.07B | Get Alert |
| 07/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.09B | Get Alert |
| 04/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $870.00M | $930.00M | $1.17B | Get Alert |
| 10/28/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $853.11M | Get Alert |
| 08/03/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $837.45M | Get Alert |
| 04/29/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $824.74M | Get Alert |
| 02/11/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $796.86M | Get Alert |
FAQ
What is the most recent guidance for Alnylam Pharmaceuticals (ALNY)?
There have been no specific sales or earnings guidance reported for Alnylam Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
